JanOne Inc. (NASDAQ: JAN) shares spike more than 50% on Tuesday after the company announced that a patent was issued that covers a method of improving nerve function using JAN101. JAN101 (formerly known as TV1001SR), is a potential treatment for...
Yumanity Therapeutics, Inc. (Nasdaq: YMTX) today announced that it has entered into definitive agreements for two strategic transactions. Up Over 46% Shares of Yumanity Therapeutics,...
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) has reported results from a Phase 2/3 Aria Study that evaluated the efficacy and safety of PRAX-114 for monotherapy...
Bristol Myers Squibb (NYSE: BMY) and Turning Point therapeutics, Inc. (NASDAQ: TPTX) has announced a definitive merger agreement under which Bristol Myers Squibb will acquire...
Repare Therapeutics Inc. (Nasdaq: RPTX) today announced that it had entered into a worldwide license and collaboration agreement with Roche. Shares Up Premarket Shares of...
TherapeuticsMD, Inc. (NASDAQ: TXMD) shares jumped about 350% Tuesday after the Company announced that it has entered into a definitive merger agreement to be acquired...
PMV Pharmaceuticals, Inc. (NASDAQ: PMVP) shares jumped about 25% on Friday, after the Company announced the online publication of the abstract for its lead program, PC14586,...
Immix Biopharma, Inc. (NASDAQ: IMMX) shares jumped more than 50% Friday after the Company revealed positive interim study data showing that after one cycle of...
NeuroMetrix, Inc. (NASDAQ: NURO) shares up about 50% Thursday after the Company announced U.S. Food and Drug Administration (FDA) De Novo authorization to market the...
SIGA Technologies, Inc. (NASDAQ: SIGA) today announced that the U.S. Food and Drug Administration (FDA) approved the intravenous (IV) formulation of TPOXX for the treatment...
Doximity, Inc. (NYSE: DOCS) reported on Wednesday its financial results for the fiscal 2022 fourth quarter and fiscal year ended March 31, 2022, in which...
PolarityTE, Inc. (NASDAQ: PTE) has reported that the U.S. Food and Drug Administration has granted a Regenerative Medicine Advanced Therapy designation to SkinTE under the...
Veru Inc. (NASDAQ: VERU) today announced that the U.S. Food and Drug Administration has agreed that the efficacy and safety data from Veru’s completed Phase...
